Market Research Logo

Diabetes & Obesity Drug Development Pipeline Review, 2016

Diabetes & Obesity Drug Development Pipeline Review, 2016

Summary


The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and the majority of the pipeline, in terms of both quantity and quality of products, is attributable to these indications. While products indicated for obesity do not currently have a large market presence, there are a large number of these products in the pipeline, with the majority in early stages of development.

The combined therapy area of diabetes and obesity presents a strong pipeline, accounting for a large proportion of the overall metabolic disorders therapy area. The majority of products are small molecules and biologics, which reflects the overall pharmacotherapeutic market trend.

An increasing pipeline presence for obesity-indicated products and overwhelming global media interest highlight the relevance of this indication and its future potential global revenues. However, the number of pharmacotherapeutic products for obesity is dwarfed by diabetes-indicated products. Given the status of obesity as a risk factor for T2DM, it is likely that the T2DM pipeline will continue to grow with the rising obesity incidence.

Scope

  • Which companies are the most active within the pipeline for diabetes and obesity?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have occurred in this disease area?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication.
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each.
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these.
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.


  • GBI Research Report Guidance
  • Executive Summary
  • Diabetes and Obesity Report Coverage
  • Type 1 Diabetes (Juvenile Diabetes) Overview
  • Type 2 Diabetes Overview
  • Obesity Overview
  • Therapeutics Development by Stage
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Figure 1: Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes), H2 2016
      • Table Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes), H2 2016
      • Table Figure 2: Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes) - Comparative Analysis, H2 2016
      • Table Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes) - Comparative Analysis, H2 2016
    • Type 2 Diabetes
      • Table Figure 3: Number of Products under Development for Type 2 Diabetes, H2 2016
      • Table Number of Products under Development for Type 2 Diabetes, H2 2016
      • Table Figure 4: Number of Products under Development for Type 2 Diabetes - Comparative Analysis, H2 2016
      • Table Number of Products under Development for Type 2 Diabetes - Comparative Analysis, H2 2016
    • Obesity
      • Table Figure 5: Number of Products under Development for Obesity, H2 2016
      • Table Number of Products under Development for Obesity, H2 2016
      • Table Figure 6: Number of Products under Development for Obesity - Comparative Analysis, H2 2016
      • Table Number of Products under Development for Obesity - Comparative Analysis, H2 2016
  • Therapeutics under Development by Companies
    • Type 1 Diabetes (Juvenile Diabetes)
      • Table Figure 7: Juvenile Diabetes - Number of Products under Development by Companies, H2 2016
      • Table Juvenile Diabetes - Number of Products under Development by Companies, H2 2016
    • Type 2 Diabetes
      • Table Figure 8: Type 2 Diabetes - Number of Products under Development by Companies, H2 2016
      • Table Type 2 Diabetes - Number of Products under Development by Companies, H2 2016
    • Obesity
      • Table Figure 9: Obesity - Number of Products under Development by Companies, H2 2016
      • Table Obesity - Number of Products under Development by Companies, H2 2016
  • Therapeutics under Investigation by Universities/Institutes
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Figure 10: Juvenile Diabetes - Number of Products under Investigation by Universities/Institutes, H2 2016
      • Table Juvenile Diabetes - Number of Products under Investigation by Universities/Institutes, H2 2016
    • Type 2 Diabetes
      • Table Figure 11: Type 2 Diabetes - Number of Products under Investigation by Universities/Institutes, H2 2016
      • Table Type 2 Diabetes - Number of Products under Investigation by Universities/Institutes, H2 2016
    • Obesity
      • Table Figure 12: Obesity - Number of Products under Investigation by Universities/Institutes, H2 2016
      • Table Obesity - Number of Products under Investigation by Universities/Institutes, H2 2016
  • Pipeline Products Glance
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Figure 13: Juvenile Diabetes - Comparative Analysis by Late Stage Development, H2 2016
      • Table Juvenile Diabetes - Comparative Analysis by Late Stage Development, H2 2016
      • Table Figure 14: Juvenile Diabetes - Comparative Analysis by Clinical Stage Development, H2 2016
      • Table Juvenile Diabetes - Comparative Analysis by Clinical Stage Development, H2 2016
      • Table Figure 15: Juvenile Diabetes - Comparative Analysis by Early Stage Products, H2 2016
      • Table Juvenile Diabetes - Comparative Analysis by Early Stage Development, H2 2016
      • Table Juvenile Diabetes - Comparative Analysis by Unknown Stage Development, H2 2016
    • Type 2 Diabetes
      • Table Figure 16: Type 2 Diabetes - Comparative Analysis by Late Stage Development, H2 2016
      • Table Type 2 Diabetes - Comparative Analysis by Late Stage Development, H2 2016
      • Table Figure 17: Type 2 Diabetes - Comparative Analysis by Clinical Stage Development, H2 2016
      • Table Type 2 Diabetes - Comparative Analysis by Clinical Stage Development, H2 2016
      • Table Figure 18: Type 2 Diabetes - Comparative Analysis by Early Stage Products, H2 2016
      • Table Type 2 Diabetes - Comparative Analysis by Early Stage Development, H2 2016
      • Table Type 2 Diabetes - Comparative Analysis by Unknown Stage Development, H2 2016
    • Obesity
      • Table Figure 19: Obesity - Comparative Analysis by Late Stage Development, H2 2016
      • Table Obesity - Comparative Analysis by Late Stage Development, H2 2016
      • Table Figure 20: Obesity - Comparative Analysis by Clinical Stage Development, H2 2016
      • Table Obesity - Comparative Analysis by Clinical Stage Development, H2 2016
      • Table Figure 21: Obesity - Comparative Analysis by Early Stage Products, H2 2016
      • Table Obesity - Comparative Analysis by Early Stage Development, H2 2016
      • Table Obesity - Comparative Analysis by Unknown Stage Development, H2 2016
  • Products under Development by Companies
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Juvenile Diabetes - Products under Development by Companies, H2 2016
    • Type 2 Diabetes
      • Table Type 2 Diabetes - Products under Development by Companies, H2 2016
    • Obesity
      • Table Obesity - Products under Development by Companies, H2 2016
  • Products under Investigation by Universities/Institutes
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Juvenile Diabetes - Products under Investigation by Universities/Institutes, H2 2016
    • Type 2 Diabetes
      • Table Type 2 Diabetes - Products under Investigation by Universities/Institutes, H2 2016
    • Obesity
      • Table Obesity - Products under Investigation by Universities/Institutes, H2 2016
  • Companies Involved in Therapeutics Development
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by AbGenomics International, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Adocia, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by AiCuris GmbH and Co KG, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Alteogen Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Amarantus Bioscience Holdings, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Ambrx, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by AntriaBio, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Aphios Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by APT Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Araim Pharmaceuticals, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Argos Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Artery Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Astellas Pharma Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by AstraZeneca Plc, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Athersys, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Atlantic Bio Sci LLC, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Axxam SpA, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Beta-Cell NV, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Biocon Limited, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Biogenomics Limited, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by BioLineRx, Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by BioLingus AG, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by BioTherapeutics Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by BirchBioMed Inc, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Boehringer Ingelheim GmbH, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Caladrius Biosciences Inc, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Cancer Prevention Pharmaceuticals, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Carlina Technologies SAS, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Compugen Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by ConjuChem, LLC, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Daewoong Pharmaceutical Co., Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Dance Biopharm Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Diabetology (Products) Ltd, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by DiaMedica Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Diamyd Medical AB, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Diasome Pharmaceuticals, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Dompe Farmaceutici S.p.A., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Eli Lilly and Company, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by enGene, Inc, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Ensol Biosciences Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by EpiVax, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Escape Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Evotec AG, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Fate Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Generex Biotechnology Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by GeNeuro SA, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Geropharm, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Gilead Sciences, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by GlaxoSmithKline Plc, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Grifols, S.A., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Heptares Therapeutics Limited, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Iltoo Pharma, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by ImmusanT, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Innopharmax Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Intrexon Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Islet Sciences, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Johnson & Johnson, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Kadimastem Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Kamada Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Kasiak Research Private Limited, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by KPI Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Lexicon Pharmaceuticals, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Ligand Pharmaceuticals, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Lonestar Heart, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by MacroGenics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Medestea Research & Production S.p.A., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by MedImmune LLC, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Medy-Tox Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Merck & Co., Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Meridigen Biotech Co., Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by MidaSol Therapeutics LP, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Novo Nordisk A/S, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Noxxon Pharma AG, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Oramed Pharmaceuticals, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Orgenesis Inc, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by OSE Immunotherapeutics, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Paras Biopharmaceuticals Finland Oy, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Parvus Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Pathfinder Cell Therapy Inc, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Pfizer Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by PharmaCyte Biotech, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by PharmaIN Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Prometheon Pharma, LLC, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Purzer Pharmaceutical Co., Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by RedHill Biopharma Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by REGiMMUNE Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Sanofi, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by SEKRIS Biomedical, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Selecta Biosciences, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Semma Therapeutics Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Sevion Therapeutics, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Strongbridge Biopharma plc , H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Therapix Biosciences Ltd., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Thermalin Diabetes, LLC, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Toleranzia AB, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Transgene Biotek Limited, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by UCB SA, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Unicyte AG, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by United Therapeutics Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by ViaCyte, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Visionary Pharmaceuticals, Inc., H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by XL-protein GmbH, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by XOMA Corporation, H2 2016
      • Table Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Zensun (Shanghai) Sci & Tech Co., Ltd., H2 2016
    • Type 2 Diabetes
      • Table Type 2 Diabetes - Pipeline by Addex Therapeutics Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Adocia, H2 2016
      • Table Type 2 Diabetes - Pipeline by Advinus Therapeutics Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Aegis Therapeutics, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by AFFiRiS AG, H2 2016
      • Table Type 2 Diabetes - Pipeline by Alize Pharma SAS, H2 2016
      • Table Type 2 Diabetes - Pipeline by AlphaMab Co., Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Alteogen Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Amarantus Bioscience Holdings, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Ambrx, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Amgen Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Anchor Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by AntriaBio, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Aphios Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by APT Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Araim Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Arisaph Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by ArisGen SA, H2 2016
      • Table Type 2 Diabetes - Pipeline by Artery Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Astellas Pharma Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by AstraZeneca Plc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Aus Bio Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Bayer AG, H2 2016
      • Table Type 2 Diabetes - Pipeline by Beta-Cell NV, H2 2016
      • Table Type 2 Diabetes - Pipeline by Betagenon AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by Biocon Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Biodel Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Biogenomics Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by BioLingus AG, H2 2016
      • Table Type 2 Diabetes - Pipeline by BioRestorative Therapies, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by BioTherapeutics Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Biscayne Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Boehringer Ingelheim GmbH, H2 2016
      • Table Type 2 Diabetes - Pipeline by Boston Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Braasch Biotech LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Bristol-Myers Squibb Company, H2 2016
      • Table Type 2 Diabetes - Pipeline by C4X Discovery Holdings PLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Cadila Pharmaceuticals Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Caldan Therapeutics Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Cardax, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Carlina Technologies SAS, H2 2016
      • Table Type 2 Diabetes - Pipeline by Carmot Therapeutics Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Celon Pharma Sp. z o.o., H2 2016
      • Table Type 2 Diabetes - Pipeline by Chipscreen Biosciences Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2016
      • Table Type 2 Diabetes - Pipeline by CJ HealthCare Corp., H2 2016
      • Table Type 2 Diabetes - Pipeline by CohBar, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by ConjuChem, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Connexios Life Sciences Pvt. Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Corium International, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by CureDM, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by CymaBay Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Daewoong Pharmaceutical Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Daiichi Sankyo Company, Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Dance Biopharm Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Delpor, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Diabetica Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Diabetology (Products) Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by DiaMedica Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Diamyd Medical AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by Diasome Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by DiscoveryBiomed, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by DNJ Pharma, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Dong-A Socio Holdings Co. Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Elcelyx Therapeutics Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Eli Lilly and Company, H2 2016
      • Table Type 2 Diabetes - Pipeline by enGene, Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Enzo Biochem, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Epichem Pty Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Esperion Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Eternygen GmbH, H2 2016
      • Table Type 2 Diabetes - Pipeline by Evotec AG, H2 2016
      • Table Type 2 Diabetes - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by FibroStatin SL, H2 2016
      • Table Type 2 Diabetes - Pipeline by Flamel Technologies S.A., H2 2016
      • Table Type 2 Diabetes - Pipeline by Generex Biotechnology Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by Genfit SA, H2 2016
      • Table Type 2 Diabetes - Pipeline by Genovate Biotechnology Co., LTD., H2 2016
      • Table Type 2 Diabetes - Pipeline by Gero Corp, H2 2016
      • Table Type 2 Diabetes - Pipeline by Geropharm, H2 2016
      • Table Type 2 Diabetes - Pipeline by Gilead Sciences, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by GlaxoSmithKline Plc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Glide Pharmaceutical Technologies Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Glucox Biotech AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by GW Pharmaceuticals Plc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by HanAll Biopharma Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Handok Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by HEC Pharm Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Heptares Therapeutics Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by HitGen LTD, H2 2016
      • Table Type 2 Diabetes - Pipeline by Hua Medicine (Shanghai) Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Hyundai Pharmaceutical Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Immuron Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Innopharmax Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Innovative Targeting Solutions Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Intarcia Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Intas Pharmaceuticals Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Integral Molecular, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Intercept Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Intrexon Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by Ionis Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Ironwood Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Islet Sciences, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Ixchel Pharma, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Japan Tobacco Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Jeil Pharmaceutical Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Jenrin Discovery, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by JHL Biotech, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Johnson & Johnson, H2 2016
      • Table Type 2 Diabetes - Pipeline by Kadimastem Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Kadmon Corporation, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Kareus Therapeutics, SA, H2 2016
      • Table Type 2 Diabetes - Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Lead Discovery Center GmbH, H2 2016
      • Table Type 2 Diabetes - Pipeline by Leading BioSciences, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Lexicon Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by LG Life Science LTD., H2 2016
      • Table Type 2 Diabetes - Pipeline by Ligand Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by LipimetiX Development Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Lonestar Heart, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Longevity Biotech, Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Magnus Life Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Medesis Pharma S.A., H2 2016
      • Table Type 2 Diabetes - Pipeline by Medestea Research & Production S.p.A., H2 2016
      • Table Type 2 Diabetes - Pipeline by MedImmune LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Mellitech SAS, H2 2016
      • Table Type 2 Diabetes - Pipeline by Merck & Co., Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Mesoblast Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Metabolic Solutions Development Company, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Metabolys SAS, H2 2016
      • Table Type 2 Diabetes - Pipeline by Metacrine, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by MicroBiome Therapeutics LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by MidaSol Therapeutics LP, H2 2016
      • Table Type 2 Diabetes - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by Moderna Therapeutics Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Naia Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Neurimmune Holding AG, H2 2016
      • Table Type 2 Diabetes - Pipeline by Neurocrine Biosciences, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by NGM Biopharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Nordic Bioscience A/S, H2 2016
      • Table Type 2 Diabetes - Pipeline by Novapeutics, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Novartis AG, H2 2016
      • Table Type 2 Diabetes - Pipeline by NovaTarg Therapeutics, Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Novo Nordisk A/S, H2 2016
      • Table Type 2 Diabetes - Pipeline by Noxxon Pharma AG, H2 2016
      • Table Type 2 Diabetes - Pipeline by Ogeda SA, H2 2016
      • Table Type 2 Diabetes - Pipeline by Omeros Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by OPKO Biologics Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by OPKO Health, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Oramed Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Orbis Biosciences Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Panacea Biotec Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Paras Biopharmaceuticals Finland Oy, H2 2016
      • Table Type 2 Diabetes - Pipeline by Peptron, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Pfizer Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by PharmaCyte Biotech, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by PharmaIN Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by PhaseBio Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Pila Pharma AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by Pivot Pharmaceuticals Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Poxel SA, H2 2016
      • Table Type 2 Diabetes - Pipeline by Prometheon Pharma, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by ProMetic Life Sciences Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Purzer Pharmaceutical Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Reata Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by ReCyte Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Red Glead Discovery AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by RegenMedTX, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by reMYND NV, H2 2016
      • Table Type 2 Diabetes - Pipeline by Renova Therapeutics Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Saniona AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by Sanofi, H2 2016
      • Table Type 2 Diabetes - Pipeline by Sanwa Kagaku Kenkyusho Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by SATT Conectus Alsace SAS, H2 2016
      • Table Type 2 Diabetes - Pipeline by SBI Pharmaceuticals Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Selvita S.A., H2 2016
      • Table Type 2 Diabetes - Pipeline by Seres Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Serodus ASA, H2 2016
      • Table Type 2 Diabetes - Pipeline by Serometrix, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Sevion Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Shanghai Fosun Pharmaceutical (Group) Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Shantani Proteome Analytics Pvt. Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Shionogi & Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Sihuan Pharmaceutical Holdings Group Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Sirona Biochem Corp, H2 2016
      • Table Type 2 Diabetes - Pipeline by SJT Molecular Research, S.L. , H2 2016
      • Table Type 2 Diabetes - Pipeline by SK Chemicals Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Sprint Bioscience AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by Starpharma Holdings Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Stelic Institute & Co., Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Strongbridge Biopharma plc , H2 2016
      • Table Type 2 Diabetes - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Taisho Pharmaceutical Holdings Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Takeda Pharmaceutical Company Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Teijin Pharma Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Theracos, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Therapix Biosciences Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Thermalin Diabetes, LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Thetis Pharmaceuticals LLC, H2 2016
      • Table Type 2 Diabetes - Pipeline by Toray Industries, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Torrent Pharmaceuticals Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Transgene Biotek Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by TWi Pharmaceuticals, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Uni-Bio Science Group Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Valeant Pharmaceuticals International, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Venenum Biodesign, L.L.C, H2 2016
      • Table Type 2 Diabetes - Pipeline by ViaCyte, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Vichem Chemie Research Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Vicore Pharma AB, H2 2016
      • Table Type 2 Diabetes - Pipeline by Viking Therapeutics, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Virobay Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by Vivus, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by vTv Therapeutics Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Vybion, Inc., H2 2016
      • Table Type 2 Diabetes - Pipeline by XBiotech Inc, H2 2016
      • Table Type 2 Diabetes - Pipeline by Xenetic Biosciences (UK) Limited, H2 2016
      • Table Type 2 Diabetes - Pipeline by Xizang Haisco Pharmaceutical Group Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by XL-protein GmbH, H2 2016
      • Table Type 2 Diabetes - Pipeline by XOMA Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by XuanZhu Pharma Co Ltd, H2 2016
      • Table Type 2 Diabetes - Pipeline by Yuhan Corporation, H2 2016
      • Table Type 2 Diabetes - Pipeline by Yungjin Pharm. Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Zealand Pharma A/S, H2 2016
      • Table Type 2 Diabetes - Pipeline by Zensun (Shanghai) Sci & Tech Co., Ltd., H2 2016
      • Table Type 2 Diabetes - Pipeline by Zydus Cadila Healthcare Limited, H2 2016
    • Obesity
      • Table Obesity - Pipeline by Abeome Corporation, H2 2016
      • Table Obesity - Pipeline by Acylin Therapeutics Inc, H2 2016
      • Table Obesity - Pipeline by Advinus Therapeutics Ltd, H2 2016
      • Table Obesity - Pipeline by Aegis Therapeutics, LLC, H2 2016
      • Table Obesity - Pipeline by Akron Molecules AG, H2 2016
      • Table Obesity - Pipeline by Alize Pharma SAS, H2 2016
      • Table Obesity - Pipeline by Amabiotics SAS, H2 2016
      • Table Obesity - Pipeline by Amgen Inc., H2 2016
      • Table Obesity - Pipeline by Aoxing Pharmaceutical Company, Inc, H2 2016
      • Table Obesity - Pipeline by Arena Pharmaceuticals, Inc., H2 2016
      • Table Obesity - Pipeline by AstraZeneca Plc, H2 2016
      • Table Obesity - Pipeline by Asubio Pharma Co., Ltd., H2 2016
      • Table Obesity - Pipeline by Athersys, Inc., H2 2016
      • Table Obesity - Pipeline by Biophytis SAS, H2 2016
      • Table Obesity - Pipeline by BioRestorative Therapies, Inc., H2 2016
      • Table Obesity - Pipeline by Boehringer Ingelheim GmbH, H2 2016
      • Table Obesity - Pipeline by Braasch Biotech LLC, H2 2016
      • Table Obesity - Pipeline by C3 Jian, Inc, H2 2016
      • Table Obesity - Pipeline by Carmot Therapeutics Inc, H2 2016
      • Table Obesity - Pipeline by Chronos Therapeutics Limited, H2 2016
      • Table Obesity - Pipeline by CohBar, Inc., H2 2016
      • Table Obesity - Pipeline by CoMentis, Inc., H2 2016
      • Table Obesity - Pipeline by Connexios Life Sciences Pvt. Ltd., H2 2016
      • Table Obesity - Pipeline by Corium International, Inc., H2 2016
      • Table Obesity - Pipeline by Daiichi Sankyo Company, Limited, H2 2016
      • Table Obesity - Pipeline by Diabetica Limited, H2 2016
      • Table Obesity - Pipeline by DiscoveryBiomed, Inc., H2 2016
      • Table Obesity - Pipeline by Eli Lilly and Company, H2 2016
      • Table Obesity - Pipeline by Esperion Therapeutics, Inc., H2 2016
      • Table Obesity - Pipeline by Eternygen GmbH, H2 2016
      • Table Obesity - Pipeline by Evotec AG, H2 2016
      • Table Obesity - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016
      • Table Obesity - Pipeline by FibroGen Inc, H2 2016
      • Table Obesity - Pipeline by Galenea Corp., H2 2016
      • Table Obesity - Pipeline by Gila Therapeutics Inc, H2 2016
      • Table Obesity - Pipeline by Gilead Sciences, Inc., H2 2016
      • Table Obesity - Pipeline by GlaxoSmithKline Plc, H2 2016
      • Table Obesity - Pipeline by GTx, Inc., H2 2016
      • Table Obesity - Pipeline by HanAll Biopharma Co., Ltd., H2 2016
      • Table Obesity - Pipeline by Handok Inc., H2 2016
      • Table Obesity - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016
      • Table Obesity - Pipeline by Hyundai Pharmaceutical Co., Ltd., H2 2016
      • Table Obesity - Pipeline by Immungenetics AG, H2 2016
      • Table Obesity - Pipeline by Intarcia Therapeutics, Inc., H2 2016
      • Table Obesity - Pipeline by Ionis Pharmaceuticals, Inc., H2 2016
      • Table Obesity - Pipeline by Ixchel Pharma, LLC, H2 2016
      • Table Obesity - Pipeline by Jenrin Discovery, Inc., H2 2016
      • Table Obesity - Pipeline by Johnson & Johnson, H2 2016
      • Table Obesity - Pipeline by Kowa Company, Ltd, H2 2016
      • Table Obesity - Pipeline by Lead Discovery Center GmbH, H2 2016
      • Table Obesity - Pipeline by Leading BioSciences, Inc., H2 2016
      • Table Obesity - Pipeline by LEO Pharma A/S, H2 2016
      • Table Obesity - Pipeline by LG Life Science LTD., H2 2016
      • Table Obesity - Pipeline by Lotus Pharmaceutical Co., Ltd., H2 2016
      • Table Obesity - Pipeline by M Pharmaceutical Inc., H2 2016
      • Table Obesity - Pipeline by Magnus Life Ltd, H2 2016
      • Table Obesity - Pipeline by MAKScientific, LLC, H2 2016
      • Table Obesity - Pipeline by MedImmune LLC, H2 2016
      • Table Obesity - Pipeline by Merck & Co., Inc., H2 2016
      • Table Obesity - Pipeline by Mitochon Pharmaceuticals, Inc., H2 2016
      • Table Obesity - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2016
      • Table Obesity - Pipeline by NeuroNano Pharma Inc, H2 2016
      • Table Obesity - Pipeline by NGM Biopharmaceuticals, Inc., H2 2016
      • Table Obesity - Pipeline by NIBEC, H2 2016
      • Table Obesity - Pipeline by Nordic Bioscience A/S, H2 2016
      • Table Obesity - Pipeline by Novo Nordisk A/S, H2 2016
      • Table Obesity - Pipeline by ObeTherapy Biotechnology, H2 2016
      • Table Obesity - Pipeline by Ogeda SA, H2 2016
      • Table Obesity - Pipeline by Omeros Corporation, H2 2016
      • Table Obesity - Pipeline by OPKO Biologics Ltd, H2 2016
      • Table Obesity - Pipeline by OPKO Health, Inc., H2 2016
      • Table Obesity - Pipeline by Orbis Biosciences Inc, H2 2016
      • Table Obesity - Pipeline by Orexigen Therapeutics, Inc., H2 2016
      • Table Obesity - Pipeline by Pfizer Inc., H2 2016
      • Table Obesity - Pipeline by PharmaIN Corporation, H2 2016
      • Table Obesity - Pipeline by Poxel SA, H2 2016
      • Table Obesity - Pipeline by Progenra, Inc., H2 2016
      • Table Obesity - Pipeline by Prometheon Pharma, LLC, H2 2016
      • Table Obesity - Pipeline by ReCyte Therapeutics, Inc., H2 2016
      • Table Obesity - Pipeline by Renova Therapeutics Inc, H2 2016
      • Table Obesity - Pipeline by Reviva Pharmaceuticals Inc., H2 2016
      • Table Obesity - Pipeline by Saniona AB, H2 2016
      • Table Obesity - Pipeline by Sanofi, H2 2016
      • Table Obesity - Pipeline by Selvita S.A., H2 2016
      • Table Obesity - Pipeline by Seoul Pharma Co., Ltd., H2 2016
      • Table Obesity - Pipeline by Shionogi & Co., Ltd., H2 2016
      • Table Obesity - Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2016
      • Table Obesity - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2016
      • Table Obesity - Pipeline by Takeda Pharmaceutical Company Limited, H2 2016
      • Table Obesity - Pipeline by Toray Industries, Inc., H2 2016
      • Table Obesity - Pipeline by Umecrine AB, H2 2016
      • Table Obesity - Pipeline by Vicore Pharma AB, H2 2016
      • Table Obesity - Pipeline by Viking Therapeutics, Inc., H2 2016
      • Table Obesity - Pipeline by WhanIn Pharmaceutical Co., Ltd., H2 2016
      • Table Obesity - Pipeline by Xenetic Biosciences (UK) Limited, H2 2016
      • Table Obesity - Pipeline by XL-protein GmbH, H2 2016
      • Table Obesity - Pipeline by Yuyu Pharma, Inc., H2 2016
      • Table Obesity - Pipeline by Zafgen Inc., H2 2016
      • Table Obesity - Pipeline by Zealand Pharma A/S, H2 2016
  • Therapeutics Assessment
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Figure 22: Juvenile Diabetes - Assessment by Monotherapy Products, H2 2016
      • Table Juvenile Diabetes - Assessment by Monotherapy Products, H2 2016
      • Table Figure 23: Juvenile Diabetes - Assessment by Combination Products, H2 2016
      • Table (Juvenile Diabetes)Assessment by Combination Products, H2 2016
      • Table Figure 24: Juvenile Diabetes - Number of Products by Top 10 Targets, H2 2016
      • Table Figure 25: Juvenile Diabetes - Number of Products by Stage and Top 10 Targets, H2 2016
      • Table Juvenile Diabetes - Number of Products by Stage and Target, H2 2016
      • Table Figure 26: Juvenile Diabetes - Number of Products by Top 10 Mechanism of Actions, H2 2016
      • Table Figure 27: Juvenile Diabetes - Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
      • Table Juvenile Diabetes - Number of Products by Stage and Mechanism of Action, H2 2016
      • Table Figure 28: Juvenile Diabetes - Number of Products by Top 10 Routes of Administration, H2 2016
      • Table Figure 29: Juvenile Diabetes - Number of Products by Stage and Top 10 Routes of Administration, H2 2016
      • Table Juvenile Diabetes - Number of Products by Stage and Route of Administration, H2 2016
      • Table Figure 30: Juvenile Diabetes - Number of Products by Top 10 Molecule Types, H2 2016
      • Table Figure 31: Juvenile Diabetes - Number of Products by Stage and Top 10 Molecule Types, H2 2016
      • Table Juvenile Diabetes - Number of Products by Stage and Molecule Type, H2 2016
    • Type 2 Diabetes
      • Table Figure 32: Type 2 Diabetes - Assessment by Monotherapy Products, H2 2016
      • Table Type 2 Diabetes - Assessment by Monotherapy Products, H2 2016
      • Table Figure 33: Type 2 Diabetes - Assessment by Combination Products, H2 2016
      • Table Type 2 Diabetes - Assessment by Combination Products, H2 2016
      • Table Figure 34: Type 2 Diabetes - Number of Products by Top 10 Targets, H2 2016
      • Table Figure 35: Type 2 Diabetes - Number of Products by Stage and Top 10 Targets, H2 2016
      • Table Type 2 Diabetes - Number of Products by Stage and Target, H2 2016
      • Table Figure 36: Type 2 Diabetes - Number of Products by Top 10 Mechanism of Actions, H2 2016
      • Table Figure 37: Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
      • Table Type 2 Diabetes - Number of Products by Stage and Mechanism of Action, H2 2016
      • Table Figure 38: Type 2 Diabetes - Number of Products by Top 10 Routes of Administration, H2 2016
      • Table Figure 39: Type 2 Diabetes - Number of Products by Stage and Top 10 Routes of Administration, H2 2016
      • Table Type 2 Diabetes - Number of Products by Stage and Route of Administration, H2 2016
      • Table Figure 40: Type 2 Diabetes - Number of Products by Top 10 Molecule Types, H2 2016
      • Table Figure 41: Type 2 Diabetes - Number of Products by Stage and Top 10 Molecule Types, H2 2016
      • Table Type 2 Diabetes - Number of Products by Stage and Molecule Type, H2 2016
    • Obesity
      • Table Figure 42: Obesity - Assessment by Monotherapy Products, H2 2016
      • Table Obesity - Assessment by Monotherapy Products, H2 2016
      • Table Figure 43: Obesity - Assessment by Combination Products, H2 2016
      • Table Obesity - Assessment by Combination Products, H2 2016
      • Table Figure 44: Obesity - Number of Products by Top 10 Targets, H2 2016
      • Table Figure 45: Obesity - Number of Products by Stage and Top 10 Targets, H2 2016
      • Table Obesity - Number of Products by Stage and Target, H2 2016
      • Table Figure 46: Obesity - Number of Products by Top 10 Mechanism of Actions, H2 2016
      • Table Figure 47: Obesity - Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
      • Table Obesity - Number of Products by Stage and Mechanism of Action, H2 2016
      • Table Figure 48: Obesity - Number of Products by Routes of Administration, H2 2016
      • Table Figure 49: Obesity - Number of Products by Stage and Routes of Administration, H2 2016
      • Table Obesity - Number of Products by Stage and Route of Administration, H2 2016
      • Table Figure 50: Obesity - Number of Products by Top 10 Molecule Types, H2 2016
      • Table Figure 51: Obesity - Number of Products by Stage and Top 10 Molecule Types, H2 2016
      • Table Obesity - Number of Products by Stage and Molecule Type, H2 2016
  • Dormant Projects
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects, H2 2016
    • Type 2 Diabetes
      • Table Type 2 Diabetes - Dormant Projects, H2 2016
    • Obesity
      • Table Obesity - Dormant Projects, H2 2016
  • Discontinued Products
    • Type 1 diabetes (Juvenile Diabetes)
      • Table Type 1 Diabetes (Juvenile Diabetes) - Discontinued Products, H2 2016
    • Type 2 Diabetes
      • Table Type 2 Diabetes - Discontinued Products, H2 2016
    • Obesity
      • Table Obesity - Discontinued Products, H2 2016
  • Product Development Milestones
    • Type 1 diabetes (Juvenile Diabetes)
    • Type 2 Diabetes
    • Obesity
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report